Technology | 2021.05.06
MEDO receives FDA approval to Revolutionize Thyroid Ultrasound.
EDMONTON, AB, May 6, 2021 /PRNewswire/ - Medo, an artificial intelligence technology start-up company headquartered in Singapore and Canada, is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration for the world\'s first tool using Artificial...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]roid-ultrasound-301285952.html
